Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 4, 2000, Pages 369-377

  Stringer, Jeffrey S A ^a,d   Rouse, Dwight J ^a   Vermund, Sten H ^b   Goldenberg, Robert L ^a   Sinkala, Moses ^c   Stinnett, Aaron A ^d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c MINISTRY OF HEALTH   (Zambia)

^d NONE

Author keywords

Adherence; Cost effectiveness analysis; Nevirapine; Perinatal transmission; Voluntary counseling; Voluntary testing

Indexed keywords

NEVIRAPINE;

AFRICA; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DELIVERY; FEMALE; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; PRENATAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0034253116     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200008010-00012     Document Type: Article

References (27)

1. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIV-NET 012 randomised trial
2. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa
3. Evidence of stable HIV seroprevalences in selected populations in Democratic Republic of Congo, Former Zaire (1988-1997)
4. Attitude of pregnant women towards HIV testing in Abidjan, Cote d'Ivoire and Bobo-Dioulasso, Burkina Faso. DITRAME Study Group (ANRS 049 Clinical Trial). Diminution de la transmission mere enfant du VIH. Agence Nationale de Recherches sur le SIDA
5. Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfeed children in Cote d'Ivoire and Burkina Faso: A double-blind placebo-controlled multicentre trial
6. The evolution of voluntary testing and counseling as an HIV prevention strategy
7. Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras
8. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial
9. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: A pharmacy claims-based analysis
10. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center
11. Effects of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985-1997
12. Short-course zidovu-dine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial
13. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group
14. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
15. Prevention of vertical transmission of HIV: Analysis of cost effectiveness of options available in South Africa
16. From cost-effectiveness ratios to resource allocation: Where to draw the line?
17. Dealing with discounting: An application to the cost-effectiveness of intracoronary thrombolysis with streptokinase
18. Costs and benefits to the mother of antenatal HIV testing: Estimates from simulation modelling
19. Modelling the costs of paediatric HIV infection and AIDS: Comparison of infected children born to screened and unscreened mothers
20. Resource allocation and the funding of HIV prevention